Research Article
Efficacy of Sorafenib Combined with Interventional Therapy on Primary Liver Cancer Patients and Its Effect on Serum AFP, VEGF, and GGT
Table 2
Comparison of patients’ overall efficacy (n (%)).
| Group | CR | PR | SD | PD | ORR | DCR |
| Group A | 24 (40.0) | 30 (50.0) | 2 (3.3) | 4 (6.7) | 54 (90.0) | 56 (93.3) | Group B | 18 (30.0) | 20 (33.3) | 10 (16.7) | 12 (20.0) | 38 (63.3) | 48 (80.0) | X2 | 1.319 | 3.429 | 5.926 | 4.615 | 11.926 | 4.615 | P | 0.251 | 0.064 | 0.015 | 0.032 | 0.001 | 0.032 |
|
|